Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Stanley J. Szefler (Denver, United States of America). Application of biomarkers and patient characteristics to personalize asthma treatment for children. International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma

Member's Comments

No comment yet.

Related content which might interest you: From guidelines to personalized treatment of children with asthma Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project) Source: Eur Respir J 2002; 20: Suppl. 38, 329s Year: 2002 Monitoring asthma in children: clinical tools Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma? Source: Eur Respir J 2001; 18: 439-441 Year: 2001 Assessing the utility of asthma medication monitoring sensors in a group of high risk asthmatic children Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Effect of patients‘ characteristics and asthma management on control Source: Eur Respir J 2005; 26: Suppl. 49, 381s Year: 2005 Identifying patients with severe asthma that will be benefit from biological therapy Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Does clinical score evaluation improve management in bronchiolitis patients? Source: Eur Respir J 2007; 30: Suppl. 51, 391s Year: 2007 Baseline characteristics of severe asthma patients initiating biologic treatment worldwide Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Patient baseline variables predict future asthma control status and risk of exacerbations Source: Annual Congress 2010 - Management of airway disease Year: 2010 A novel monitoring device in predicting asthma exacerbation in children Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006 The influence of patient education on asthma treatment Source: Eur Respir J 2003; 22: Suppl. 45, 243s Year: 2003 A novel asthma monitoring system for asthma management in children Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005 Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Linking phenotypes to personalised treatments in asthma and COPD Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 How to manage a patient with asthma Source: ERS Satellites 2021 Year: 2021 A digital therapy for proactively managing exacerbations and delivering therapeutic benefit to patients with moderate to severe asthma Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Evaluation of the difficult-to-treat severe asthma patient in the clinic Source: Eur Respir Mon 2011; 51: 16-27 Year: 2011